On November 28, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers announcing further details on the continuous evaluation process.
Effective today, INESSS is initiating the consultation period for drug products for which a listing request was filed between October 2, 2017 and ... Read More
29
Nov2017
16
Nov2017
On November 13, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a Notice to Manufacturers announcing further details on the continuous evaluation process.
As of December 1, 2017, manufacturers can submit an application for registration to INESSS for a new innovative drug product or a ... Read More
08
Nov2017
On November 7, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers announcing further details on the continuous evaluation process.
INESSS would like to inform manufacturers that as of November 1, 2017, new terms and conditions apply for manufacturers who wish to request ... Read More
03
Nov2017
On November 2, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) announced they have now published the list of drug products currently undergoing review under their new continuous evaluation process on their website.
Citizens, health professionals, patients and their caregivers, as well as their associations or ... Read More
17
Oct2017
On October 12, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers announcing the details on the process for the mandatory notification required for submissions. As of November 1, 2017, manufacturers are required to inform INESSS at least 2 months in advance ... Read More
29
Sep2017
On September 29, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released a notice to manufacturers announcing the details on the process for the admissibility of submission applications for registration. A manufacturer can submit an application for registration to INESSS only when all required documents are ... Read More
08
Sep2017
On September 7, 2017, the Institut national d’excellence en santé et en services sociaux (INESSS) released the list of medications for which a registration application was submitted for the February 2018 list update as well as the medications pending a Health Canada Notice of Compliance to be reviewed.
Health professionals, citizens, ... Read More
21
Aug2017
On August 18, 2017, the Institut national d’excellence en santé et en services sociaux (INESSS) released a Notice to Drug Manufacturers and Wholesalers describing the following changes to the INESSS process.
List Update Schedule in 2018
The Minister of Health and Social Services has authorized nine updates to the List ... Read More
13
Jun2017
The Minister of Health and Social Services has authorized one additional update to the List of Medications covered by the basic prescription drug insurance plan and the List of Medications – Institutions in 2018: February 1. The submission deadline for innovative drug products is August 11, 2017.
Please note that only ... Read More
09
Jun2017
On June 2, 2017, Québec’s Institut national d’excellence en santé et en services sociaux (INESSS) released new submission guidelines, including a pre-NOC review procedure, to be implemented immediately. Topics to be covered include:
New Pre-NOC Review Procedure & Submission Criteria
New Submission Guidelines
New Submission Requirements
Potential Changes to List ... Read More